| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.00021 | 1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.00038 | 1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0003 | 1 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.00029 | 1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00046 | 1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.00048 | 1 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.0035 | 1 |